Clinical trial
A Prospective, Multi-center, Single Arm Study Evaluating the Express™ Renal Premounted Stent System in the Treatment of Atherosclerotic Lesions in the Aortorenal Ostium.
NCT00597142 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Single Arm Study Evaluating the Express™ Renal Premounted Stent System in the Treatment of Atherosclerotic Lesions in the Aortorenal Ostium.
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- October 31, 2009
- Enrollment
- 100 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerotic lesions in the aortorenal ostium